Literature DB >> 3790730

Cytogenetic and histologic correlations in malignant lymphoma.

P R Koduru, D A Filippa, M E Richardson, S C Jhanwar, S R Chaganti, B Koziner, B D Clarkson, P H Lieberman, R S Chaganti.   

Abstract

Although a number of studies have indicated correlations between histologic subtypes of tumors and certain nonrandom chromosome changes, cytogenetic studies of lymphoma are in an early stage compared to those of leukemia. No comprehensive analysis of available data has so far been attempted in the literature either. Here we present an analysis of chromosome changes and their correlation with subtypes of lymphoma studied by conventional histology and cell surface markers, as observed in two sets of data: a group of 65 karyotypically abnormal tumors sequentially ascertained and studied by us during the period January 1, 1984 to April 30, 1985, and a larger data set derived by combining our data with those from two published series from the University of Minnesota that are comparable to our data. These combined data, which comprise the largest data set on the cytogenetics of lymphomas assembled so far, enabled a comprehensive analysis of correlation between chromosome change and tumor histology and the patterns of chromosome instability in these tumors. We found several significant associations, some previously described and others now recognized, between nonrandom chromosome gains, breaks, translocations, and deletions and histologic subtypes of tumors that characterize lymphomas. The data indicate that finding of chromosome breaks at certain sites (eg, 8q24, 14q32, 18q21) is of diagnostic value in dealing with cases of unusual lymphoma. Furthermore, nonrandom chromosome breakage exhibited three distinct patterns that reflected three levels of etiologically relevant genetic change.

Entities:  

Mesh:

Year:  1987        PMID: 3790730

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.

Authors:  E Athan; D R Foitl; D M Knowles
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

Review 2.  Cytogenetics of malignant lymphomas.

Authors:  C Fonatsch
Journal:  Blut       Date:  1988-09

3.  The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT).

Authors:  L Pan; T C Diss; D Cunningham; P G Isaacson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

5.  Chromosome analysis of 30 cases of non-Hodgkin's lymphoma.

Authors:  G Chenevix-Trench; J A Brown; G B Tyler; F G Behm
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

6.  Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.

Authors:  S K Juneja; M M Wolf; I A Cooper
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

7.  Chromosomal characteristics of malignant lymphoma.

Authors:  E W Fleischman; E L Prigogina; G W Ilynskaya; N A Probatova; L N Konstantinova; G V Kruglova; M A Volkova; D S Osmanov
Journal:  Hum Genet       Date:  1989-07       Impact factor: 4.132

8.  Molecular characterization of primary mediastinal B cell lymphoma.

Authors:  P Tsang; E Cesarman; A Chadburn; Y F Liu; D M Knowles
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

9.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

10.  Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma.

Authors:  W Fiedler; H J Weh; W Zeller; C Fonatsch; J Hillion; C Larsen; B Wörmann; D K Hossfeld
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.